|
1
|
Bosetti C, Levi F, Rosato V, et al: Recent
trends in colorectal cancer mortality in Europe. Int J Cancer.
129:180–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng S and Cai SR: Colorectal cancer
epidemiology and prevention study in China. Chin Ger J Clin Oncol.
2:72–75. 2003. View Article : Google Scholar
|
|
3
|
Chen Y, Zhang YZ, Zhou ZG, et al:
Identification of differentially expressed genes in human
colorectal adenocarcinoma. World J Gastroenterol. 12:1025–1032.
2006.
|
|
4
|
Zhang C and Chen Y: Electronic cloning and
validating of the suppression subtractive hybridization EST
ES274070 of human colorectal adenocarcinoma. US Chin J Lymphol
Oncol. 6:83–88. 2007.
|
|
5
|
Zhu JJ, Jiang Q, Yuan LX, et al: Screening
and verification of the siRNA targeted to the FBXL20 gene. Chin J
Biochem Mol Biol. 27:237–243. 2011.
|
|
6
|
Skowyra D, Craig KL, Tyers M, et al: F-box
proteins are receptors that recruit phosphorylated substrates to
the SCF ubiquitin-ligase complex. Cell. 91:209–219. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bustin SA, Benes V, Garson JA, et al: The
MIQE guidelines: minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bai C, Sen PK, Hofman K, et al: SKP1
connects cell cycle regulators to the ubiquitin proteolysis
machinery through a novel motif, the F-box. Cell. 86:263–274. 1996.
View Article : Google Scholar
|
|
9
|
Craig KL and Tyers M: The F-box: a new
motif for ubiquitin dependent proteolysis in cell cycle regulation
and signal transduction. Prog Biophys Mol Biol. 72:299–328. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shirane M, Hatakeyama S, Hattori K, et al:
Common pathway for the ubiquitination of IkappaBalpha, IkappaBbeta,
and IkappaBepsilon mediated by the F-box protein FWD1. J Biol Chem.
274:28169–28174. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008.
|
|
12
|
Kudo Y, Guardavaccaro D, Santamaria PG, et
al: Role of F-Box protein beta-Trcp1 in mammary gland development
and tumorigenesis. Mol Cell Biol. 24:8184–8194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bromberg KD, Kluger HM, Delaunay A, et al:
Increased expression of the E3 ubiquitin ligase RNF5 is associated
with decreased survival in breast cancer. Cancer Res. 67:8172–8179.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsai YC, Mendoza A, Mariano TM, et al: The
ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAl1
for degradation. Nat Med. 13:1504–1509. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yokoi S, Yasui K, Saito-Ohara F, et al: A
novel target gene, SKP2, within the 5p13 amplicon that is
frequently detected in small cell lung cancers. Am J Pathol.
161:207–216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
von der Lehr N, Johansson S and Larsson
LG: Implication of the ubiquitin/proteasome in Myc-regulated
transcription. Cell Cycle. 2:403–407. 2003.PubMed/NCBI
|
|
17
|
Masuda TA, Inoue H, Sonoda H, et al:
Clinical and biological significance of S-phase kinase-associated
protein 2 (Skp2) gene expression in gastric carcinoma: modulation
of malignant phenotype by Skp2 overexpression, possibly via p27
proteolysis. Cancer Res. 62:3819–3825. 2002.
|
|
18
|
Gnarra JR and Dressler GR: Expression of
Pax-2 in human renal cell carcinoma and growth inhibition by
antisense oligonucleotides. Cancer Res. 55:4092–4098.
1995.PubMed/NCBI
|
|
19
|
Kim M, Yan Y, Lee K, et al: Ectopic
expression of Von Hippel-Lindau tumor suppressor induces apoptosis
in 786-O renal cell carcinoma cells and regresses tumor growth of
786-O cells in nude mouse. Biochemical Biophys Res Commun.
320:945–950. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maxwell PH, Wiesener MS, Chanq GW, et al:
The tumour suppressor protein VHL targets hypoxia-inducible factors
for oxygen-dependent proteolysis. Nature. 399:271–275. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Segditsas S and Tomlinson I: Colorectal
cancer and genetic alterations in the Wnt pathway. Oncogene.
25:7531–7537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung P, Menssen A, Mayr D and Hermeking H:
AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci
USA. 105:15046–15051. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chu IM, Hengst L and Slingerland JM: The
Cdk inhibitor p27 in human cancer: prognostic potential and
relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Koldobskiy MA, Chakraborty A, Werner JK
Jr, et al: p53-mediated apoptosis requires inositol
hexakisphosphate kinase-2. Proc Natl Acad Sci USA. 107:20947–20951.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim Y, Reifenberger G, Lu D, et al:
Influencing the Wnt signaling pathway in multiple myeloma.
Anticancer Res. 31:725–730. 2011.PubMed/NCBI
|
|
26
|
Tian X, Liu Z, Niu B, et al:
E-cadherin/β-catenin complex and the epithelial barrier. J Biomed
Biotechnol. 2011:5673052011.
|
|
27
|
Jiang Q, Zhang C, Zhu J, et al: The set
gene is a potential oncogene in human colorectal adenocarcinoma and
oral squamous cell carcinoma. Mol Med Rep. 4:993–999.
2011.PubMed/NCBI
|
|
28
|
Willert K, Shibamoto S and Nusse R:
Wnt-induced dephosphorylation of axin releases beta-catenin from
the axin complex. Genes Dev. 13:1768–1773. 1999. View Article : Google Scholar : PubMed/NCBI
|
